What is changing in the management of obesity?
People in England over the age of 18 living with obesity and weight-related health
issues, will be able to access the weight loss drug Tirzepatide (Mounjaro®).
Tirzepatide is currently prescribed for the treatment of type 2 diabetes mellitus but
will now also be available for weight loss purposes
For more information, please the see the Tirzepatide (Mounjaro®) FAQs (PDF).